Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeneca Growth Regulatory News (HYG)

Share Price Information for Seneca Growth (HYG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.50
Bid: 10.00
Ask: 17.00
Change: 0.00 (0.00%)
Spread: 7.00 (70.00%)
Open: 13.50
High: 13.50
Low: 13.50
Prev. Close: 13.50
HYG Live PriceLast checked at -
Seneca Growth Capital VCT is an Investment Trust

To provide shareholders with an attractive income and capital return by investing its funds in a portfolio of both unquoted and quoted UK MedTech companies which meet the relevant criteria under the VCT Rules.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reduction of Capital

17 Dec 2018 16:43

RNS Number : 7400K
Seneca Growth Capital VCT PLC
17 December 2018
 

ANNOUNCEMENT FOLLOWING REDUCTION OF CAPITAL

 

Seneca Growth Capital VCT Plc

 

Reduction of Capital

 

The Board of Seneca Growth Capital VCT Plc (the "Company") announces that the proposed Share Premium Reduction and Capital Redemption Reserve Reduction have now taken place.

 

On 15 December 2017 Seneca Growth Capital VCT Plc issued a circular to its shareholders to convene a general meeting on 19 January 2018, at which (amongst other things) shareholders were asked to approve a reduction of capital by the cancellation of the share premium account of the Company as at the date an order is made confirming the cancellation by the High Court (the "Share Premium Reduction"). The amount credited to the share premium account, and now cancelled, arose as a result of the issue of B ordinary shares on 23 August 2018 and 27 September 2018 at a premium.

 

At its annual general meeting on 5 April 2018, the shareholders of the Company were asked to approve a restructuring of the issued share capital of the Company pursuant to which ordinary shares of £0.50 each were sub-divided and re-designated into ordinary shares of £0.01 and deferred shares of £0.49 each (the "Deferred Shares"). At the same meeting, shareholders gave the Company authority to buy back and cancel all of the Deferred Shares in addition to approving a reduction of capital by the cancellation of the capital redemption reserve of the Company, as at the date an order is made confirming the cancellation by the High Court (the "Capital Redemption Reserve Reduction" and together with the Share Premium Reduction being referred to as the "Capital Reductions").

 

On 7 December 2018, the High Court of Justice in Manchester confirmed the Capital Reduction. The court order approving the Capital Reductions was registered by the Registrar of Companies on 11 December 2018 and, therefore, the Capital Reductions became effective on that date.

 

The reserve created by the Capital Redemption Reserve Reduction can be used at any time at the Board's discretion once the accounts for 2018 have been lodged at Companies House; however use of the reserve created from Share Premium Reduction cannot be used for returning any funds to shareholders for a period of three years following the end of the accounting period in which the allotment of B ordinary shares to which the share premium related, due to restrictions imposed by VCT regulations.

 

There is no change to the number of ordinary shares or B ordinary shares in issue as a result of the Capital Reductions, and for the avoidance of doubt, the rights attaching to those shares following the Capital Reductions remain unchanged.

 

For further information, please contact:

John Hustler, Seneca Growth Capital VCT Plc at john.hustler@btconnect.com

Richard Manley, Seneca Growth Capital VCT Plc at Richard.Manley@senecapartners.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAKAXFDNPFFF
Date   Source Headline
31st Mar 20205:30 pmGNWNet Asset Value(s)
26th Mar 20204:31 pmGNWAGM Venue Change
13th Mar 20204:14 pmGNWInterim Dividend
10th Mar 20202:28 pmGNWIssue of Equity
10th Mar 20207:00 amGNWB Share Net Asset Value
3rd Mar 20204:30 pmGNWIssue of Supplementary Prospectus
27th Feb 20207:00 amGNWFinal Results
9th Dec 20195:45 pmGNWDirectorate Change
27th Nov 20192:45 pmGNWIssue of Equity
20th Nov 20194:00 pmGNWDuplicate: Second Interim Dividend
28th Oct 20197:00 amGNWSecond interim dividend
10th Oct 20196:30 pmGNWDirector/PDMR Shareholding
8th Oct 20191:55 pmGNWIssue of Equity
8th Oct 20197:00 amGNWUpdate for the quarter ended 30 September 2019
17th Jul 20198:00 amGNWCorrection: Offer for Subscription
16th Jul 20195:27 pmGNWOffer for Subscription
10th Jul 20195:20 pmGNWHalf-year report
18th Jun 20199:16 amRNSHolding(s) in Company
10th Jun 20196:14 pmRNSResult of AGM
16th May 20197:00 amRNSSecond Interim Dividend
29th Apr 20198:52 amRNSFinal Results
25th Apr 20197:00 amRNSNet Asset Value(s)
5th Apr 201912:47 pmRNSIssue of Equity
3rd Apr 201912:46 pmRNSIssue of Equity
29th Mar 20195:20 pmRNSRevised timetable
13th Mar 201912:03 pmRNSExtension of Offer
7th Mar 20193:22 pmRNSIssue of Equity
6th Mar 201910:30 amRNSInterim Dividend
6th Mar 20198:39 amRNSNet Asset Value(s)
28th Dec 20187:00 amRNSDividend Declaration
19th Dec 20182:21 pmRNSIssue of Equity
18th Dec 20189:56 amRNSUpdate on Hallmarq
17th Dec 20184:43 pmRNSReduction of Capital
29th Nov 20181:53 pmRNSHolding(s) in Company
23rd Nov 20187:00 amRNSUpdate for the quarter ended 30 September 2018
27th Sep 201810:59 amRNSIssue of Equity
23rd Apr 201812:43 pmRNSHolding(s) in Company
22nd May 201712:59 pmRNSHolding(s) in Company
24th Feb 201610:42 amRNSScancell to present at Biotech Capital
16th Feb 20159:47 amRNSHoldings in Company
24th Oct 20133:53 pmRNSInterim Management Statement
22nd Mar 20127:00 amRNSFinal Results
29th Oct 201011:18 amRNSInterim Management Statement
7th Sep 201011:34 amRNSDirector's Dealings
5th Aug 20107:00 amRNSHalf Yearly Report
7th May 20107:00 amRNSResults of AGM and IMS to 31 March 2010
31st Mar 20104:48 pmRNSAnnual Financial Report
22nd Jan 201012:26 pmRNSDeclaration of Interim Dividend
24th Sep 20099:43 amRNSDirector's Dealing
22nd Sep 200910:10 amRNSPortfolio Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.